Search Result "trioxaquines"


Hybrid Drugs for Malaria

Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 2970-2985
Author(s): J. J. Walsh, A. Bell

MALARIA Synthesis of Hybrid Molecules and Inhibitors of Falcipain for Use as Therapeutic Agents in Treatment of Malaria

Ebook: Recent Advances in the Synthesis of Organic Compounds to Combat Neglected Tropical Diseases
Volume: 1 Year: 2014
Author(s): Renata Barbosa de Oliveira,Marcela Silva Lopes,Saulo Fehelberg Pinto Braga
Doi: 10.2174/9781608059027114010009

4-Aminoquinoline Based Molecular Hybrids as Antimalarials: An Overview

Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 14 Year: 2014 Page: 1706-1733
Author(s): Sunny Manohar,Mohit Tripathi,Diwan S. Rawat

Anti-Viral

Journal: Current Bioactive Compounds
Volume: 1 Issue: 1 Year: 2005 Page: 54-58
Author(s): Bentham Science Publishers

Antimalarial Drug Development: Past to Present Scenario

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2009 Page: 1447-1469
Author(s): Meenakshi Dhanawat, Nirupam Das, Ramesh C. Nagarwal, S. K. Shrivastava

Review Article

Quinoline Containing Side-chain Antimalarial Analogs: Recent Advances and Therapeutic Application

Journal: Current Topics in Medicinal Chemistry
Volume: 20 Issue: 8 Year: 2020 Page: 617-697
Author(s): Mukesh C. Joshi,Timothy J. Egan

Subject Index To Volume 6

Journal: Infectious Disorders - Drug Targets
Volume: 7 Issue: 1 Year: 2007 Page: vii-vii
Author(s): Bentham Science Publishers

Subject Index To Volume 5

Journal: Anti-Infective Agents in Medicinal Chemistry
Volume: 6 Issue: 1 Year: 2007 Page: iii-vi
Author(s):

New Trends in Anti-Malarial Agents

Journal: Current Medicinal Chemistry
Volume: 9 Issue: 1 Year: 2002 Page: 1435-1456
Author(s): Michel Frederich, Jean-Michel Dogne, Luc Angenot, Patrick De Mol

Previous   Next

Go To   Results 1 - 1 of 33

Apply Filters

Volume Years
Article Type
    Publication Title
      Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy